VLA 0.00% $1.75 viralytics limited

Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-8

  1. 7,872 Posts.
    lightbulb Created with Sketch. 3365
    Amazing what effect just two days and a tit-bit of news from the company can have on the SP... not to mention the morale of shareholders. GLTA
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.